HUNTINGTON — GLP-1 agonists like Ozempic, Trulicity, Mounjaro, Victoza and Wegovy started as a way to treat diabetes but have since become popular tools for weight loss. Dr. Matthew Christiansen ...

The growth was primarily fueled by strong performances from Mounjaro and Zepbound ... of its revenue in the U.S. from its leading drugs Trulicity, Verzenio and Taltz. The company operates in ...

With weight loss drugs such as Ozempic and Mounjaro seemingly able to melt the pounds away, you might well think you'll never need a 'diet plan' again. Alas, you'd be wrong. As a leading weight ...

Mounjaro, manufactured by Lilly ... head-to-head battles began in 2012 with Lilly’s once-weekly injectable Trulicity taking on Novo Nordisk’s once-daily injectable Victoza — and the gamble ...

Tirzepatide, the active ingredient in Eli Lilly's diabetes drug Mounjaro, may be an effective alternative to painful daily treatment for a rare disorder, according to research published Jan. 29 in ...

Eli Lilly's GLP-1 drugs, Mounjaro (for diabetes ... These include drugs like Verzenio, Trulicity, Jardiance, Taltz, Humalog, Cyramza, and Olumiant. Recently, Eli Lilly garnered approval for ...

Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people eligible, but will be made available in stages to limit the financial impact.